Correlation Between Roche Holding and Chugai Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roche Holding and Chugai Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and Chugai Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roche Holding AG and Chugai Pharmaceutical Co, you can compare the effects of market volatilities on Roche Holding and Chugai Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of Chugai Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and Chugai Pharmaceutical.

Diversification Opportunities for Roche Holding and Chugai Pharmaceutical

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Roche and Chugai is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding AG and Chugai Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chugai Pharmaceutical and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding AG are associated (or correlated) with Chugai Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chugai Pharmaceutical has no effect on the direction of Roche Holding i.e., Roche Holding and Chugai Pharmaceutical go up and down completely randomly.

Pair Corralation between Roche Holding and Chugai Pharmaceutical

Assuming the 90 days horizon Roche Holding AG is expected to generate 0.63 times more return on investment than Chugai Pharmaceutical. However, Roche Holding AG is 1.59 times less risky than Chugai Pharmaceutical. It trades about 0.21 of its potential returns per unit of risk. Chugai Pharmaceutical Co is currently generating about 0.05 per unit of risk. If you would invest  28,500  in Roche Holding AG on December 28, 2024 and sell it today you would earn a total of  5,500  from holding Roche Holding AG or generate 19.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Roche Holding AG  vs.  Chugai Pharmaceutical Co

 Performance 
       Timeline  
Roche Holding AG 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Roche Holding AG are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Roche Holding reported solid returns over the last few months and may actually be approaching a breakup point.
Chugai Pharmaceutical 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Chugai Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Chugai Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Roche Holding and Chugai Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roche Holding and Chugai Pharmaceutical

The main advantage of trading using opposite Roche Holding and Chugai Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, Chugai Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chugai Pharmaceutical will offset losses from the drop in Chugai Pharmaceutical's long position.
The idea behind Roche Holding AG and Chugai Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities